The US Preventive Services Task Force strategy captures less than 5% of postmenopausal women 50 to 54 years of age who will have a major osteoporotic fracture (MOF) within the next 10 years, according to an analysis presented at the American Society for Bone and Mineral Research 2014 Annual Meeting.
Montreal, QC—Researchers analyzed studies of patient adherence to daily and weekly medications to evaluate the impact of dosing frequency on medication adherence. Osteoporosis was the condition selected by the investigators because there are many daily and weekly medications available for this indication. Their results showed that patients on weekly regimens are 90% more likely to be adherent than those on daily regimens.
Seville, Spain––Is it cost-effective to screen for osteoporosis using the prescreening Fracture Risk Assessment Tool (FRAX) scores in all women 60 years and older? In a presentation at the 2014 European Society for Clinical and Economic Aspects of Osteoporosis meeting, a group of researchers from Belgium and Holland made the case that it is cost-effective.
Seville, Spain—A nurse-driven intervention appears to significantly improve osteoporosis care in older adults who present to the hospital after a fall, according to a preliminary study.
To simplify the process of identifying patients who have osteoporosis or are at elevated risk of the common condition, a company has created the Osteoporosis Advisor.
Washington, DC—Odanacatib, an investigational agent, was effective in building bone mass in women with postmenopausal osteoporosis who did not respond to 3 years of treatment with alendronate (Fosamax). By Phoebe Starr

Results 1 - 6 of 6
  • Rheumatology Practice Management
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology